RESUMEN
BACKGROUND AND AIM: Necrotizing Enterocolitis (NEC) is an inflammation-associated ischemic necrosis of the intestine. To investigate the effects of extra virgin olive oil (EVOO) on inflammation, oxidative stress, apoptosis, and histological changes in NEC-induced newborn rats. MATERIALS AND METHODS: 24 rats were randomly divided into three groups: control, NEC and NEC + EVOO. NEC induction was performed using hypoxia-hyperoxia, formula feeding, and cold stress. The NEC + EVOO group received 2 ml/kg EVOO with high phenolic content by gavage twice a day for 3 days. 3 cm of bowel including terminal ileum, cecum, and proximal colon was excised. RESULTS: Weight gain and clinical disease scores were significantly higher in the NEC + EVOO group than in the NEC group (p < 0.001). EVOO treatment caused significant decreases in IL1ß, IL6 levels (p = 0.016, p = 0.029 respectively) and EGF, MDA levels (p = 0.032, p = 0.013 respectively) compared to NEC group. Significant decreases were observed in IL6 gene expression in the NEC + EVOO group compared to the NEC group (p = 0.002). In the group NEC + EVOO, the number of Caspase-3 positive cells was found to be significantly reduced (p < 0.001) and histopathological examination revealed minimal changes and significantly lower histopathological scores (p < 0.001). CONCLUSION: Phenol-rich EVOO prevents intestinal damage caused by NEC by inhibiting inflammation, oxidative stress, apoptosis.
Asunto(s)
Enterocolitis Necrotizante , Interleucina-6 , Ratas , Animales , Aceite de Oliva/uso terapéutico , Aceite de Oliva/farmacología , Interleucina-6/metabolismo , Enterocolitis Necrotizante/patología , Estrés Oxidativo , Apoptosis , Inflamación , Fenoles/farmacología , Fenoles/uso terapéutico , Modelos Teóricos , Animales Recién NacidosRESUMEN
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by several pathological hallmarks, including the deposition of amyloid-ß (Aß) plaques, neurofibrillary tangles, blood-brain barrier (BBB) dysfunction, increased oxidative stress, and neuroinflammation. Current treatment options include monoclonal antibody drugs, acetylcholinesterase, and n-methyl-d-aspartate (NMDA) antagonists. Although those treatments provide some improvements in patients' quality of life, they fail to prevent or cure AD. Current research aims to identify novel targets and tools for AD prevention and modification. In this context, several studies showed the beneficial effect of the Mediterranean diet in the prevention and treatment of AD. One integral component of the Mediterranean diet is olive oil and extra-virgin olive oil (EVOO), which is high in phenolic compounds. EVOO and other olive-related phenolic compounds have been shown to reduce the risk of developing mild cognitive impairment (MCI) and AD. In this review, we discuss the mechanisms by which EVOO and phenolic compounds exert neuroprotective effects, including modulation of AD pathologies and promotion of cognitive health. Findings indicate that EVOO and its phenolic constituents influence key pathological processes of AD, such as Aß aggregation, tau phosphorylation, and neuroinflammation, while also enhancing BBB integrity and reducing oxidative stress. The human studies cited reveal a consistent trend where the consumption of olive oil is associated with cognitive benefits and a decreased risk of AD and related dementias. In conclusion, EVOO and its phenolic compounds hold promising potential for the prevention and treatment of AD, representing a significant shift towards more effective strategies against this complex neurodegenerative disorder.
Asunto(s)
Enfermedad de Alzheimer , Animales , Humanos , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/prevención & control , Aceite de Oliva/uso terapéutico , Acetilcolinesterasa , Enfermedades Neuroinflamatorias , Calidad de Vida , Péptidos beta-Amiloides , Fenoles/uso terapéuticoRESUMEN
BACKGROUND: Hand Foot Syndrome (HFS) is a frequent adverse effect observed in patients undergoing capecitabine chemotherapy, often leading to treatment disruptions and dose adjustments. Elevated C-Reactive Protein (hs-CRP) levels have been associated with the development of HFS. This study aimed to assess the potential of unrefined Extra Virgin Olive Oil (EVOO) supplementation in mitigating HFS and hs-CRP elevation among individuals receiving capecitabine chemotherapy. METHODS: Between November 2022 and May 2023, forty-five eligible participants were enrolled in this randomized trial. Patients with advanced colorectal or breast cancer were randomly allocated into three groups: an intervention group receiving unrefined EVOO supplementation (30 mL per day) alongside capecitabine, a placebo group receiving refined extra light olive oil (ELOO) supplementation (30 mL per day) alongside capecitabine, and a control group receiving capecitabine alone. The masking of both placebo and intervention groups was ensured through identical packaging and instructions, maintaining participant and physician blindness to the assigned treatments. Randomization, achieved via computer-generated sequences, ensured even distribution among the three groups. RESULTS: HFS incidences were notably lower in the EVOO group (13.3%) compared to the placebo (66.7%) and control (80%) groups. Instances of Grade 2 or more severe HFS were observed in 20% of placebo and 40% of control group patients. No cases of severe HFS were reported in the EVOO group. Moreover, EVOO supplementation led to a significant reduction in hs-CRP levels when contrasted with the placebo and control groups. These findings suggest that EVOO may serve as a preventive measure against HFS and exhibit anti-inflammatory effects in patients undergoing capecitabine chemotherapy. CONCLUSION: This study demonstrates the potential benefits of incorporating unrefined EVOO into the regimen of patients undergoing capecitabine chemotherapy. EVOO supplementation was associated with lower incidences of HFS and a reduction in hs-CRP levels, indicating its possible role in preventing HFS development and mitigating inflammation.
Asunto(s)
Neoplasias de la Mama , Neoplasias Colorrectales , Síndrome Mano-Pie , Femenino , Humanos , Neoplasias de la Mama/tratamiento farmacológico , Proteína C-Reactiva , Capecitabina/efectos adversos , Síndrome Mano-Pie/etiología , Síndrome Mano-Pie/prevención & control , Síndrome Mano-Pie/tratamiento farmacológico , Aceite de Oliva/uso terapéutico , Neoplasias Colorrectales/tratamiento farmacológicoRESUMEN
Angiopoietin-like proteins (ANGPTLs) -3, -4, and -8 are regulators of lipid metabolism and have been shown to respond to changes in dietary fats. It is unknown how ANGPTLs respond to cottonseed oil (CSO) and olive oil (OO) consumption in a population with hypercholesterolemia. The purpose of this study was to determine the impact of CSO vs. OO consumption on fasting and postprandial ANGPTL responses in adults with hypercholesterolemia. We hypothesized that CSO would have lower fasting and postprandial ANGPTL responses compared with OO. Forty-two adults with high cholesterol completed a single-blind, randomized trial comparing CSO (n = 21) vs. OO (n = 21) diet enrichment. An 8-week partial outpatient feeding intervention provided â¼60% of the volunteers' total energy expenditure (â¼30% of total energy expenditure as CSO or OO). The remaining 40% was not controlled. Fasting blood draws were taken at pre-, mid-, and postintervention visits. Volunteers consumed a high saturated fat meal followed by 5 hours of blood draws pre- and postvisits. Fasting ANGPTL3 had a marginally significant treatment by visit interaction (P = .06) showing an increase from pre- to postintervention in CSO vs. OO (CSO: 385.1 ± 27.7 to 440.3 ± 33.9 ng/mL; OO: 468.2 ± 38.3 to 449.2 ± 49.5 ng/mL). Both postprandial ANGPTL3 (P = .02) and ANGPTL4 (P < .01) had treatment by visit interactions suggesting increases from pre- to postintervention in OO vs. CSO with no differences between groups in ANGPTL8. These data show a worsening (increase) of postprandial ANGPTLs after the OO, but not CSO, intervention. This aligns with previously reported data in which postprandial triglycerides were protected from increases compared with OO. ANGPTLs may mediate protective effects of CSO consumption on lipid control. This trial was registered at clinicaltrials.gov (NCT04397055).
Asunto(s)
Hipercolesterolemia , Hormonas Peptídicas , Adulto , Humanos , Aceite de Oliva/farmacología , Aceite de Oliva/uso terapéutico , Aceite de Semillas de Algodón , Aceites de Plantas/farmacología , Aceites de Plantas/uso terapéutico , Proteína 3 Similar a la Angiopoyetina , Método Simple Ciego , Grasas de la Dieta , Triglicéridos , Periodo Posprandial , Estudios Cruzados , Proteína 8 Similar a la Angiopoyetina , Hormonas Peptídicas/uso terapéuticoRESUMEN
Chronic inflammation and insulin resistance lead to metabolic syndrome and there is an urgent need to establish effective treatments and prevention methods. Our previous study reported that obese model Zucker (fa/fa) rats fed with ozonated olive oil alleviated fatty liver and liver damage by suppressing inflammatory factors. However, differences among animal species related to the safety and efficacy of ozonated olive oil administration remain unclear. Therefore, this study investigated the effects of oral intake of ozonated olive oil on lipid metabolism in normal mice and mice in the obesity model. C57BL/6J and db/db mice were fed the following AIN-76 diets for four weeks: the mice were either fed a 0.5% olive oil diet (Control diet) or 0.5% ozonated olive oil diet (Oz-Olive diet) in addition to 6.5% corn oil. The results indicated that four weeks of Oz-Olive intake did not adversely affect growth parameters, hepatic lipids or serum parameters in normal C57BL/6J mice. Subsequent treatment of db/db mice with Oz-Olive for four weeks reduced the levels of hepatic triglycerides, serum alkaline phosphatase, and serum insulin. These effects of Oz-Olive administration might be due to suppression of fatty acid synthesis activity and expression of lipogenic genes, as well as suppression of inflammatory gene expression. In conclusion, this study confirmed the safety of Oz-Olive administration in normal mice and its ability to alleviate hepatic steatosis by inhibiting fatty acid synthesis and inflammation in obese mice.
Asunto(s)
Hígado Graso , Ratones , Ratas , Animales , Aceite de Oliva/farmacología , Aceite de Oliva/uso terapéutico , Aceite de Oliva/metabolismo , Ratones Endogámicos C57BL , Ratas Zucker , Hígado Graso/metabolismo , Hígado/metabolismo , Ratones Endogámicos , Obesidad/tratamiento farmacológico , Obesidad/metabolismo , Ácidos Grasos/metabolismo , Inflamación/metabolismo , Ratones ObesosRESUMEN
OBJECTIVE@#To observe the effect of amygdalin on liver fibrosis in a liver fibrosis mouse model, and the underlying mechanisms were partly dissected in vivo and in vitro.@*METHODS@#Thirty-two male mice were randomly divided into 4 groups, including control, model, low- and high-dose amygdalin-treated groups, 8 mice in each group. Except the control group, mice in the other groups were injected intraperitoneally with 10% carbon tetrachloride (CCl4)-olive oil solution 3 times a week for 6 weeks to induce liver fibrosis. At the first 3 weeks, amygdalin (1.35 and 2.7 mg/kg body weight) were administered by gavage once a day. Mice in the control group received equal quantities of subcutaneous olive oil and intragastric water from the fourth week. At the end of 6 weeks, liver tissue samples were harvested to detect the content of hydroxyproline (Hyp). Hematoxylin and eosin and Sirius red staining were used to observe the inflammation and fibrosis of liver tissue. The expressions of collagen I (Col-I), alpha-smooth muscle actin (α-SMA), CD31 and transforming growth factor β (TGF-β)/Smad signaling pathway were observed by immunohistochemistry, quantitative real-time polymerase chain reaction and Western blot, respectively. The activation models of hepatic stellate cells, JS-1 and LX-2 cells induced by TGF-β1 were used in vitro with or without different concentrations of amygdalin (0.1, 1, 10 µmol/L). LSECs. The effect of different concentrations of amygdalin on the expressions of liver sinusoidal endothelial cells (LSECs) dedifferentiation markers CD31 and CD44 were observed.@*RESULTS@#High-dose of amygdalin significantly reduced the Hyp content and percentage of collagen positive area, and decreased the mRNA and protein expressions of Col-I, α-SMA, CD31 and p-Smad2/3 in liver tissues of mice compared to the model group (P<0.01). Amygdalin down-regulated the expressions of Col-I and α-SMA in JS-1 and LX-2 cells, and TGFβ R1, TGFβ R2 and p-Smad2/3 in LX-2 cells compared to the model group (P<0.05 or P<0.01). Moreover, 1 and 10 µmol/L amygdalin inhibited the mRNA and protein expressions of CD31 in LSECs and increased CD44 expression compared to the model group (P<0.05 or P<0.01).@*CONCLUSIONS@#Amygdalin can dramatically alleviate liver fibrosis induced by CCl4 in mice and inhibit TGF-β/Smad signaling pathway, consequently suppressing HSCs activation and LSECs dedifferentiation to improve angiogenesis.
Asunto(s)
Ratas , Masculino , Ratones , Animales , Factor de Crecimiento Transformador beta/metabolismo , Amigdalina/uso terapéutico , Células Endoteliales/metabolismo , Aceite de Oliva/uso terapéutico , Ratas Wistar , Proteínas Smad/metabolismo , Cirrosis Hepática/metabolismo , Hígado , Factor de Crecimiento Transformador beta1/metabolismo , Transducción de Señal , Colágeno Tipo I/metabolismo , Tetracloruro de Carbono , Células Estrelladas HepáticasRESUMEN
Fundamentos: El aceite de oliva, grasa fundamental de la dieta mediterránea, ha contribuido a un descenso de la obesidad en diversos estudios epidemiológicos. Se desconoce si por sí mismo puede disminuir el peso con independencia de la dieta utilizada. El objetivo de este trabajo fue determinar la eficacia del aceite de oliva en la reducción ponderal. Métodos: Revisión sistemática con metaanálisis de ensayos controlados aleatorizados (ECA) de al menos 12 semanas de intervención sobre adultos sin eventos cardiovasculares previos, para estimar el efecto de una dieta enriquecida con aceite de oliva sobre el peso, cintura e índice de masa corporal. La búsqueda se realizó en PubMed, Embase, Cochrane plus, Web of Science, Ovid, Scopus, Biblioteca Virtual en Salud (BVS), Tesis Doctorales en Red (TDR), hasta diciembre de 2016. No se restringió idioma, sexo ni patología de base. Utilizamos Stata14 SE para la síntesis de datos. Resultados: Se identificaron 490 estudios, de ellos sólo 11 estudios cumplieron los criterios de inclusión. Una dieta enriquecida con aceite de oliva redujo más el peso que una dieta control -0,92 kg, IC 95% (-1,16,-0,67), p heterogeneidad =0,1; disminuyó la cintura en -0,60 cm, IC 95% ( -1,17,-0,04), p heterogeneidad = 0,6; y descendió el IMC en -0,90, IC 95% (-0,91, -0,88), p heterogeneidad < 0,001. El efecto favorable fue cuando el aceite se suplementó de forma líquida y no con cápsulas. Conclusiones: Una dieta enriquecida con aceite de oliva puede ser una importante estrategia de control ponderal en personas sin eventos cardiovasculares previos
Background: Olive oil, as fundamental fat in the Mediterranean diet, has contributed to a decrease in obesity in several epidemiological studies. It is unknown whether olive oil itself can decrease the weight independently of the diet used. The objective of this work was to determine the efficacy of olive oil in reducing weight. Methods: Systematic review of meta-analysis of randomized controlled trials (RCTs) of at least 12 weeks of intervention on adults without previous cardiovascular events to estimate the effect of an olive-enriched diet on weight, waist and body mass index. The search was performed in PubMed, Embase, Cochrane plus, Web of Science, Ovid, Scopus, Virtual Health Library (BVS), Theses and Dissertations Online (TDX) until December 2016. No language, gender or underlying pathology was restricted. We used Stata14 SE for data synthesis. Results: 490 studies were identified, of which only 11 studies met the inclusion criteria. A diet enriched in olive oil reduced weight more than control diet: -0.92 kg, 95% CI (-1.16, -0.67), p heterogeneity = 0.1; decreased waist circumference in -0.60 cm, 95% CI (-1.17, -0.04), p heterogeneity = 0.6; and diminished BMI in -0.90, 95% CI (-0.91, -0.88), p heterogeneity < 0.001. The benefits were seen when olive oil was supplemented in its natural state and not when capsules were given. Conclusions: A diet enriched with olive oil can be an important weight control strategy in people without previous cardiovascular events
Asunto(s)
Humanos , Aceite de Oliva/uso terapéutico , Obesidad/dietoterapia , Pérdida de Peso , Sobrepeso/dietoterapia , Programas de Reducción de Peso/estadística & datos numéricos , Índice de Masa Corporal , Resultado del Tratamiento , Pesos y Medidas Corporales/estadística & datos numéricosRESUMEN
RESUMEN: Los bisfosfonatos son potentes inhibidores de la resorción ósea. El aceite de oliva (O) presenta propiedades anti-inflamatorias y anti-oxidantes. Estudiar el efecto del tratamiento combinado de alendronato (AL) y pamidronato (PA) por vía subcutánea y de O vía oral sobre la regeneración tisular de cavidades óseas neoformadas.: 54 ratas macho de la línea Wistar, se dividieron en 6 grupos. Grupo control (C), recibieron solución salina vía subcutánea. Grupo (AL) recibió 0,5 mg de AL/Kg de peso corporal de por vía subcutánea. Grupo (PA) recibió de igual manera que el grupo anterior. Grupo (O) fue tratado con aceite de oliva con la dieta, 50 g/ Kg de comida. Grupo (ALO) recibió tratamiento combinado con AL y O. Grupo (PAO) recibió de igual tratamiento. Los sacrificios para la toma de muestras fueron a los 15, 30, 60 y 90 días. Para los estudios histopatológicos los cortes fueron teñidos con HE y observados con microscopía óptica. Los estudios estadísticos se realizaron a través del análisis de la variancia. A los quince días las áreas de los osteocitos del grupo PA se diferencian significativamente sólo respecto al grupo AL. En cuanto a la Densidad trabecular se observa un incremento de tejido óseo en todos los grupos. O mejora cualitativamente la estructura del hueso trabecular y cortical, preservando la mineralización, el tamaño y la estructura de los cristales minerales Esto sugiere que O representa una opción terapéutica prometedora para la prevención y tratamiento de las patologías óseas.
ABSTRACT: Bisphosphonates are potent inhibitors of bone resorption. Olive oil (O) has anti-inflammatory and anti-oxidant properties. To study the effect of combined treatment with alendronate (AL) and pamidronate (PA) subcutaneously or orally, and on tissue regeneration of newly formed bone cavities, we divided 54 male Wistar rats into 6 groups. Control group (C) received saline subcutaneously. Group (AL) received 0.5 mg of AL / kg body weight subcutaneously. Group (PA) received the same as the previous group. (O) was treated with olive oil diet, 50 g / kg of food. Group (ALO) received combined treatment with AL and O. Group (PAO) received the same treatment. The animals were euthanized for sampling at 15, 30, 60 and 90 days. For histopathology sections were stained with HE and observed these with light microscopy. Statistical studies were performed by analysis of variance. Fifteen days osteocytes areas of the PA group were significantly different only for the AL group. As the density increased trabecular bone tissue was observed in all groups. O qualitatively improved the structure of trabecular and cortical bone mineralization while preserving the size and structure of the mineral crystals. This suggests that O represents a promising therapeutic option for prevention and treatment of bone diseases.
Asunto(s)
Animales , Masculino , Ratas , Implantes Dentales , Periimplantitis , Ratas Wistar , Alendronato/administración & dosificación , Alendronato/uso terapéutico , Aceite de Oliva/uso terapéutico , Pamidronato/administración & dosificación , Pamidronato/uso terapéutico , HistologíaRESUMEN
Introducción. El objetivo del estudio fue evaluar la eficacia y seguridad de un nuevo pediculicida en la erradicación del Pediculus humanus capitis. Material y métodos. Se diseñó un ensayo clínico aleatorizado en el que se seleccionaron niños con edades entre los 5 y los 15 años, en los que se diagnosticó pediculosis. El tratamiento se administró en los días 1 y 7 tras su selección, y fueron evaluados en 4 visitas (días 2, 7, 9 y 14). El producto en evaluación con aceite de oliva saponificado fue Inex Pediculicide Soap®, que fue comparado con Paranix®, con un mecanismo de acción similar. La variable principal de eficacia fue la erradicación del parásito en el día 14, realizándose el análisis por intención de tratar. Resultados. Participaron 6 pediatras pertenecientes a 5 centros de salud de la Comunidad de Madrid (España) y una clínica privada. Se seleccionaron 45 niños, de los que el 75,6% eran niñas (n=34). La media de edad fue de 7,1 años (IC 95% 6,3-7,9), perteneciendo el 80% de los niños a la clase social media. El 82,2% tenían antecedentes de pediculosis previas. La eficacia a los 14 días fue del 76,2% (IC 95% 52,8-91,8) en el grupo tratado con Inex Pediculicide Soap®, y del 79,2% (IC 95% 57,9-92,9) en el grupo de Paranix® (NNT=33,3). No se registraron efectos adversos al tratamiento. Conclusiones. Los 2 productos en evaluación se mostraron eficaces y seguros en el tratamiento de erradicación del Pediculus humanus capitis, sin diferencias estadísticamente significativas entre ellos (AU)
Introduction. The aim of the study was to evaluate the efficacy and safety of a new pediculicide in the eradication of Pediculus humanus capitis infestation. Material and methods. A randomised clinical trial was designed, in which children aged between 5 and 15 years diagnosed with pediculosis were selected. Treatment was administered on days 1 and 7 after selection, and they were evaluated in 4 visits (day 2, 7, 9, and 14). The product under evaluation with saponified olive oil was Inex Pediculicide Soap®, which was compared with Paranix®, with a similar mechanism of action. The primary efficacy endpoint was the eradication of the parasite by day 14 (louse-free rate), using an intention to treat analysis. Results. Six paediatricians from 5 Primary Health Care centres in the Community of Madrid (Spain) and one private clinic participated in the study. A total of 45 children were included, of which 75.6% were girls (n=34). The mean age was 7.1 years (95% CI 6.3-7.9). The large majority (80%) were middle class, and 82.2% had a history of previous pediculosis. The efficacy at 14 days was 76.2% (95% CI 52.8-91.8) in the group treated with Inex Pediculicide Soap® group, and 79.2% (95% CI 57.9-92.9) in Paranix® group (NNT=33.3). No adverse effects were observed with treatment. Conclusions. The 2 products were effective and safe in the eradication therapy Pediculus humanus capitis, with no statistical differences (AU)
Asunto(s)
Humanos , Masculino , Femenino , Preescolar , Niño , Adolescente , Pediculus capitis/uso terapéutico , Infestaciones por Piojos/epidemiología , Infestaciones por Piojos/prevención & control , Erradicación de la Enfermedad/métodos , Aceite de Oliva/uso terapéutico , Resultado del Tratamiento , Evaluación de Eficacia-Efectividad de Intervenciones , Cumplimiento de la Medicación/estadística & datos numéricosRESUMEN
Introduction: Scientific evidence indicates that adherence to the Mediterranean diet protects against the deterioration of cognitive status and depressive symptoms during aging. However, few studies have been conducted in elderly non-institutionalized subjects. Objective: This study evaluated the relation between the adherence to the Mediterranean dietary pattern and cognitive status and depressive symptoms in an elderly population over 75 years. Methods: A cross-sectional study was conducted in a Mediterranean city (Garrucha, Spain) in 79 elderly people over 75 (36 men and 41 women). Adherence to the Mediterranean dietary pattern was determined using the Mediterranean Diet Adherence Screener (MEDAS). Cognitive function was determined by the Mini Mental State Examination (MMSE), and depressive symptoms were assessed by the Geriatric Depression Scale (GDS). Results: Most of population showed a very high adherence to the Mediterranean diet pattern and optimal cognitive and affective status. They consumed olive oil as their main source of fat, high levels offish and fruit, low levels of foods with added sugars, and a low consumption of red meat. A significant relation between the MEDAS and MMSE scores was found. However, no relationship was observed between the MEDAS and GDS. Conclusions: The Mediterranean diet pattern was positively related with the cognitive function, although the infl uence of a healthy dietary pattern on the symptomatology of depression was unclear. However, an effective strategy against cognitive function and depression would be to improve physical activity rates, establish lifelong healthy eating habits, and consume a nutritionally-rich diet in order to enhance quality of life of the elderly (AU)
Introducción: la evidencia científica indica que la adherencia al patrón de dieta Mediterránea protege contra el deterioro del estado cognitivo y los síntomas depresivos durante el envejecimiento. Sin embargo, se han realizado pocos estudios en ancianos no institucionalizados. Objetivo: este estudio evaluó la relación entre la adhesión al patrón de dieta mediterránea, el estado cognitivo y los síntomas depresivos en una población anciana de 75 años de vida independiente. Métodos: el estudio transversal se llevó a cabo en una ciudad mediterránea (Garrucha, Almería, España) en 79 adultos mayores de más de 75 años (36 hombres y 41 mujeres). La adhesión al patrón de dieta mediterránea se determinó utilizando el test Mediterranean Diet Adherence Screener (MEDAS). La función cognitiva se determinó con el test Mini Mental State Examination (MMSE), y los síntomas depresivos se evaluaron con la Escala de Depresión Geriátrica (GDS). Resultados: la mayoría de la población mostró una alta adhesión al patrón de dieta mediterránea y un estado cognitivo y afectivo óptimos. Consumían aceite de oliva como principal fuente de grasa, un elevado consumo de pescado y fruta, y un bajo consumo de carne roja y de alimentos con azúcares añadidos. Se encontró una relación significativa entre las puntuaciones del MMSE y MEDAS. Sin embargo, no se observó relación entre los resultados de MEDAS y GDS. Conclusiones: el patrón de dieta mediterránea se relacionó positivamente con la función cognitiva, pero la influencia de un patrón de dieta saludable en la sintomatología de la depresión no resultó claro. Sin embargo, una estrategia eficaz para mantener la función cognitiva y disminuir la sintomatología de depresión podría ser mejorar las tasas de actividad física, establecer hábitos alimenticios saludables durante la vida y consumir una dieta saludable con el fin de mejorar la calidad de vida de las personas mayores (AU)
Asunto(s)
Humanos , Masculino , Femenino , Anciano , Anciano de 80 o más Años , Dieta Mediterránea , Salud del Anciano Institucionalizado , Trastornos del Conocimiento/dietoterapia , Depresión/dietoterapia , Aceite de Oliva/uso terapéutico , Conducta Alimentaria/fisiología , Cooperación del Paciente , Servicios de Salud para Ancianos , Trastornos del Conocimiento/complicaciones , Depresión/complicaciones , Estudios Transversales/métodos , Calidad de VidaRESUMEN
Objetivo: Conocer la eficacia del aceite de oliva frente a los ácidos grasos hiperoxigenados en la prevención de las úlceras por presión. Metodología: Revisión sistemática de la literatura con metaanálisis sobre la eficacia del aceite de oliva virgen extra (AOVE) frente a los ácidos grasos hiperoxigenados (AGHO) en la prevención de las úlceras por presión (UPP). Búsqueda de estudios en bases de datos bibliográficas sin límite de fechas ni de idiomas. Se incluyeron ensayos clínicos aleatorizados (ECA) que comparasen el uso de AOVE y de AGHO en la prevención de las UPP. Cada artículo fue revisado utilizando la guía de valoración crítica de ensayos clínicos del CASP y también se valoró la calidad de la evidencia mediante el sistema GRADE. Se realizó el metaanálisis (efectos fijos) calculando la diferencia de riesgo con su intervalo de confianza del 95%. También se midió la heterogeneidad del mismo mediante la Q de Cochran y la I2 . Resultados: Se identificaron inicialmente 16 artículos, de los cuales se excluyeron 13 a partir de título y resumen por tratarse de artículos sobre el uso del aceite de oliva en otras patologías. Se incluyeron 2 ECA con una puntuación CASP > 5 y buena calidad de evidencia. En los estudios incluidos, ambos productos mostraron igual eficacia preventiva. La diferencia de riesgo estimada en el metaanálisis incluye el valor 0 en su intervalo de confianza, lo que indica que no hay diferencias entre los grupos de comparación. Conclusión: El AOVE es al menos igual de eficaz que los AGHO en la prevención de UPP
Aim: To determine the efficacy of olive oil against hyperoxygenated fatty acids in preventing pressure ulcers. Methodology: Systematic review of the clinical literature with meta-analysis about the effectiveness of extra virgin olive oil in relation to hyperoxygenated fatty acids in preventing pressure ulcers (PU). A literature search was conducted in bibliographic databases. Randomized clinical trials which comparing the use of extra virgin olive oil and HOFA in preventing pressure ulcers were included. The methodological quality and evidence of the studies was assessed according to the guidelines of the Critical Appraisal Skills Program (CASP) and de GRADE system respectively. A meta-analysis (fixed effects model) was carried out using risk difference with a 95% confidence interval. Also heterogeneity was measured by Q Cochran and I2 . Results: 16 articles were initially identified. 13 articles were excluded from title and summary for being articles related to olive oil in other pathologies. Finally, 2 randomized controlled trials were including after overcoming the CASP> 5 score and obtain adequate quality of evidence. In the included studies, both products showed the same preventive efficacy. The risk difference estimated in the metaanalysis includes the value 0 in the IC, which indicates there are no differences between the comparison groups. Conclusions: Extra virgin olive oil is at least as effective as the HOFA in preventing pressure ulcers
Asunto(s)
Humanos , Aceite de Oliva/uso terapéutico , Úlcera por Presión/prevención & control , Ácidos Grasos/uso terapéutico , Resultado del TratamientoRESUMEN
ABSTRACT Liquid-Crystalline Systems represent active compounds delivery systems that may be able to overcome the physical barrier of the skin, especially represented by the stratum corneum. To obtain these systems, aqueous and oily components are used with surfactants. Of the different association structures in such systems, the liquid-crystalline offer numerous advantages to a topical product. This manuscript presents the development of liquid-crystalline systems consisting, in which the oil component is olive oil, its rheological characterizations, and the location of liquid crystals in its phase map. Cytotoxic effects were evaluated using J-774 mouse macrophages as the cellular model. A phase diagram to mix three components with different proportions was constructed. Two liquid crystalline areas were found with olive oil in different regions in the ternary diagram with two nonionic surfactants, called SLC1 (S1) and SLC2 (S2). These systems showed lamellar liquid crystals that remained stable during the entire analysis time. The systems were also characterized rheologically with pseudoplastic behavior without thixotropy. The texture and bioadhesion assays showed that formulations were similar statistically (p < 0.05), indicating that the increased amount of water in S2 did not interfere with the bioadhesive properties of the systems. In vitro cytotoxic assays showed that formulations did not present cytotoxicity. Olive oil-based systems may be a promising platform for skin delivery of drugs.
RESUMO Os cristais líquidos representam um sistema de liberação de substâncias ativas capazes de vencer a barreira cutânea, representada especialmente pelo estrato córneo. Água, óleo e tensoativos são misturados para se obter esses sistemas. Diferentes estruturas podem ser formadas nesses sistemas, as quais oferecem muitas vantagens para os produtos de uso tópico. Esse trabalho visou ao desenvolvimento de sistemas líquido-cristalinos preparados com óleo de oliva, sua caracterização reológica e a identificação das fases cristalinas no diagrama ternário. Efeitos citotóxicos foram avaliados usando células de rato como modelo celular. Construiu-se um diagrama de fases que mistura três componentes em diferentes proporções. Duas áreas de cristal líquido, denominadas SLC1 (S1) e SLC2 (S2), foram encontradas com óleo de oliva em diferentes regiões no diagrama ternário preparado com dois diferentes tensoativos não-iônicos. Esses sistemas mostraram fase cristalina lamelar, que permaneceu estável durante o tempo estudado. Os sistemas foram também caracterizados reologicamente e apresentaram comportamento pseudoplástico com tixotropia. Os ensaios de textura e bioadesão mostraram que as formulações foram similares (p < 0.05), indicando que o aumento da quantidade de água em S2 não interferiu nas propriedades bioadesivas dos sistemas. Os ensaios de citotoxicidade mostraram que as formulações não foram citotóxicas. Sistemas à base de óleo de oliva são interessantes para a liberação de fármacos na pele.
Asunto(s)
Nanotecnología/métodos , Aceite de Oliva/uso terapéutico , Reología/clasificación , Cristales Líquidos/análisis , Liberación de FármacosRESUMEN
Non-alcoholic fatty liver disease (NAFLD) is directly associated with insulin resistance and oxidative stress. In NAFLD is established a reduction in n-3 LCPUFA (EPA + DHA) levels and hepatic activity of transcription factor PPAR-alpha. EPA and DHA inhibit lipogenesis and stimulate fatty acid oxidation in the liver. Extra virgin olive oil (EVOO) has important antioxidant properties. This study evaluated the prevention of insulin resistance and prevention of depletion of hepatic antioxidant defense inC57BL/6J mice fed high-fat diet (HFD), supplemented with n-3 LCPUFA plus EVOO. HFD generated insulin resistance and hepatic steatosis, together with significant reduction in i) n-3 LCPUFA hepatic levels, ii) DNA binding activity of PPAR-alpha, iii) activity of antioxidant enzymes (catalase and superoxide dismutase), respect to control group (fed with control diet). Supplementation with n-3 LCPUFA plus EVOO prevent development insulin resistance and attenuate increased of fat in liver (p < 0.05), together with a normalization of i) DNA binding activity of PPAR-á, ii) activity of antioxidant enzymes (catalase and superoxide dismutase) and iii) reducing depletion of n-3 LCPUFA levels in liver tissue, compared to the control group (p < 0.05). Supplementation with n-3 LCPUFA plus EVOO reduced hepatic steatosis and prevent development of insulin resistance, along with preserving the antioxidant defense in liver. Projecting the use of this mixture of AGPICL n-3 plus EVOO as a potential treatment of NAFLD.
Asunto(s)
Masculino , Animales , Ratones , Aceite de Oliva/uso terapéutico , /uso terapéutico , Dieta Alta en Grasa , Suplementos Dietéticos , Enfermedad del Hígado Graso no Alcohólico/dietoterapia , Aceite de Oliva/farmacología , /farmacología , Catalasa , Catalasa/fisiología , Hígado , Estrés Oxidativo , Superóxido DismutasaRESUMEN
Objetivo: Analizar el efecto sobre el Índice de Hígado Graso (FLI, Fatty Liver Index) de la intervención con dieta mediterránea enriquecida con aceite de oliva virgen extra o frutos secos frente a un grupo control con una dieta baja en grasas. Metodología: Participantes del ensayo PREDIMED-Málaga, libres de enfermedad cardiovascular basalmente, pero con alto riesgo de desarrollarla. Al inicio, al año y a los 3, 5 y 6 años se les realizó mediciones antropométricas y toma de muestras de sangre para calcular el FLI. Se usaron modelos lineales mixtos para explorar los efectos fijos de los 3 grupos de intervención sobre el FLI, y sus interacciones con el tiempo. Resultados: Cumplían los criterios de participación en el estudio 276 participantes. La edad media fue de 67 años, con un 66% de mujeres. La prevalencia basal de HGNA estimado fue del 57%. El cambio temporal del FLI en el grupo control aumentó con el tiempo (1,13±0,4; p=0,006). En el grupo DietMed+AOVE la evolución fue similar a la de este, aunque por debajo (−3,90±1,9; p=0,038), y en DietMed+FS fue significativamente menor (−1,63±0,62; p=0,009). En el DietMed+FS la evolución del cambio del IMC fue 0,100 puntos menor al año en comparación con el grupo control (p=0,004). En el grupo de control, el cambio del perímetro de cintura aumentó significativamente con el tiempo (0,61±0,16cm/año; p<0,001) en contraste con DietMed+AOVE(−0,51±0,22; p=0,019). Conclusiones: La intervención dietética con dieta mediterránea podría retrasar o enlentecer la progresión natural del HGNA, siendo beneficiosa para la prevención y el tratamiento del mismo. No obstante, se necesitan estudios que ayuden a corroborar las conclusiones obtenidas (AU)
Objective: To analyze the effect of an intervention with a Mediterranean diet supplemented with either extra virgin olive oil or nuts, on the fatty liver index (FLI), compared to a low-fat control diet. Methods: Participants of the PREDIMED-Malaga trial, free from cardiovascular disease at baseline, but with a high risk to develop it, were included in this study. Anthropometric measurements were assessed and blood samples were taken to calculate participants FLI at study baseline and after one, 3, 5 and 6 years. Mixed linear models were used to explore the fixed effects of the 3 intervention groups on the FLI as well as their interaction with time. Results: A total of 276 participants were included in the study. Average participant age was 67 years, with 66% of participants being women. The baseline prevalence of NAFL was 57%. The change in the FLI of the control group increased significantly over time (1.13±0.41; P=.006). In the MedDiet+EVOO group, the time trend of the change in the FLI was similar to that of the control group, although it was seen to be lower (−3.90±1.9; P=.038). In the MedDiet+Nuts group, the trend was significantly lower than that of the control group (−1.63±0.62; P=.009). In the MedDiet+Nuts group, the trend of changes in participants BMI was 0.100 points lower per year compared to the control group (P=.004). In the control group, the change in waist circumference increased significantly over time (0.61±0.16cm/year; P<.001) in contrast to the MedDiet+EVOO group, in which this variable remained stable (−0.51±0.22; P=.019). Conclusions: A dietary intervention consisting of a Mediterranean diet could delay or slow down the natural progression of NAFL, thus, being beneficial for its prevention and treatment. However, further studies supporting these conclusions have yet to be carried out (AU)
Asunto(s)
Humanos , Hígado Graso/prevención & control , Dieta Mediterránea , Terapia Nutricional , Resultado del Tratamiento , Evaluación de Eficacia-Efectividad de Intervenciones , Factores de Riesgo , Hígado Graso/dietoterapia , Prevención Primaria , Aceite de Oliva/uso terapéuticoRESUMEN
No disponible